richard s. finn, md, regarding the updated imbrave150 data from asco gi 2021

Published 3 years ago • 130 plays • Length 2:44

Download video MP4
Download video MP3

Similar videos

3:05

richard s. finn, md, tells us about the safety profile of atezolizumab & bevacizumab from imbrave150
2:01

richard s. finn, md, considers whether updated results from imbrave150 are practice-changing
2:13

richard s. finn, md, offers opinion on the role of frontline atezolizumab bevacizumab in hcc
3:53

asco gi: updates in keynote-177, imbrave150 & claridhy
2:39

namrata vijayvergia, md, discusses updates from the imbrave150 trial as presented at asco gi 2021
4:35

richard s. finn, md, elaborates on promising developments in the second-line treatment of hcc
1:59

richard s. finn, md, offers opinion on the broader role of i-o in the management of hcc
3:03

prodentim - ((🚨new beware🚨)) - prodentim review - prodentim reviews - pro dentim oral supplement
3:42

imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
1:30:37

the global precambrian lips record - richard ernst
3:05

imbrave150: updated data on atezo plus bev versus sorafenib in hcc
1:25

richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
1:12

richard finn, md, shares his thoughts on the role of systemic therapy in hcc
3:05

highlights in hcc from asco gi 2021
1:25

richard s. finn, md, outlines the next steps if an hcc patient fails 1st line therapy
7:48

imbrave150 phase iii design, results, and practical implications
5:44

imbrave150 regimen: managing varices
4:39

tanios bekaii-saab, md, facp, offers opinion on the updated keynote-177 as presented at asco gi 2021
2:17

richard finn, md, speculates on combined checkpoint inhibition in hcc & biliary tract cancer
6:36

tanios bekaii-saab, md, facp, summarizes data regarding circulating tumor cells from asco gi 2021
5:12

safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
4:25

imbrave150 in unresectable hcc

Clip.africa.com - Privacy-policy